136 related articles for article (PubMed ID: 18215579)
1. Cardiac defibrillators, Kant, and the categorical imperative.
Ribeiro AL; Duarte RH
Am Heart J; 2008 Feb; 155(2):e15; author reply e17. PubMed ID: 18215579
[No Abstract] [Full Text] [Related]
2. Revascularization versus implantable cardioverter-defibrillators to prevent sudden death in patients with severe left ventricular dysfunction.
Weintraub WS
Circulation; 2001 Sep; 104(13):1457-8. PubMed ID: 11571235
[No Abstract] [Full Text] [Related]
3. Primary prevention: a necessity after myocardial infarction with left ventricular dysfunction.
Valk S; Jordaens L
Europace; 2009 Apr; 11(4):407-8. PubMed ID: 19279027
[No Abstract] [Full Text] [Related]
4. Ethical issues with implantable defibrillators.
Veenhuyzen GD; Simpson CS
Pacing Clin Electrophysiol; 2005 Feb; 28(2):173-4; author reply 174. PubMed ID: 15679652
[No Abstract] [Full Text] [Related]
5. Ethical issues with implantable defibrillators.
Brennan FJ
Pacing Clin Electrophysiol; 2004 Jul; 27(7):897-8. PubMed ID: 15271005
[No Abstract] [Full Text] [Related]
6. Comments on ethical issues with implantable defibrillators by F. James Brennan.
Rahmoeller G
Pacing Clin Electrophysiol; 2004 Jul; 27(7):899. PubMed ID: 15271006
[No Abstract] [Full Text] [Related]
7. Sudden death after myocardial infarction--who needs prophylaxis, and when?
Buxton AE
N Engl J Med; 2005 Jun; 352(25):2638-40. PubMed ID: 15972871
[No Abstract] [Full Text] [Related]
8. Primary prevention implantable cardioverter-defibrillators: economics and ethics.
Silver MT
Am Heart Hosp J; 2005; 3(3):205-6. PubMed ID: 16106144
[No Abstract] [Full Text] [Related]
9. Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD? Implantable cardioverter defibrillator implantation guidelines based solely on left ventricular ejection fraction do not apply to adults with congenital heart disease.
Triedman JK
Circ Arrhythm Electrophysiol; 2008 Oct; 1(4):307-16; discussion 316. PubMed ID: 19808423
[No Abstract] [Full Text] [Related]
10. Predicting the future: risk stratification for sudden cardiac death in patients with left ventricular dysfunction.
Passman R; Goldberger JJ
Circulation; 2012 Jun; 125(24):3031-7. PubMed ID: 22711668
[No Abstract] [Full Text] [Related]
11. [Indications for implantable automatic ventricular defibrillators. A report from the Heart Rhythm Group of the French Society of Cardiology].
Aliot E; Chauvin M; Daubert JC; Frank R; Jondeau G; Leclercq JF; Le Heuzey JY;
Arch Mal Coeur Vaiss; 2006 Feb; 99(2):141-54. PubMed ID: 16555698
[No Abstract] [Full Text] [Related]
12. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery.
Suliman FA
N Engl J Med; 1998 Apr; 338(17):1228. PubMed ID: 9556393
[No Abstract] [Full Text] [Related]
14. Time dependence of defibrillator benefit postcoronary revascularization.
Pascale P; Fromer M
J Am Coll Cardiol; 2007 Jan; 49(1):124-5; author reply 125. PubMed ID: 17207734
[No Abstract] [Full Text] [Related]
15. ICD for primary prophylaxis of sudden cardiac death: an Indian perspective.
Naik N; Juneja R
J Assoc Physicians India; 2007 Apr; 55 Suppl():47-53. PubMed ID: 18376491
[No Abstract] [Full Text] [Related]
16. Implantable cardioverter defibrillator therapy for patients with less severe left ventricular dysfunction.
Exner DV
Curr Opin Cardiol; 2009 Jan; 24(1):61-7. PubMed ID: 19077818
[TBL] [Abstract][Full Text] [Related]
17. Implantable cardioverter-defibrillator and mortality in dialysis patients.
Saravanan P; Davidson NC
Am J Cardiol; 2009 Jun; 103(11):1623-4. PubMed ID: 19463528
[No Abstract] [Full Text] [Related]
18. Microvolt T-wave alternans and the selective use of implantable cardioverter defibrillators for primary prevention: a cost-effectiveness study.
Filion KB; Xie X; van der Avoort CJ; Dendukuri N; Brophy JM
Int J Technol Assess Health Care; 2009 Apr; 25(2):151-60. PubMed ID: 19331707
[TBL] [Abstract][Full Text] [Related]
19. Comments on ethical issues with implantable defibrillators by F. James Brennan.
Moss AJ
Pacing Clin Electrophysiol; 2004 Jul; 27(7):900. PubMed ID: 15271007
[No Abstract] [Full Text] [Related]
20. Use of traditional and biventricular implantable cardiac devices for primary and secondary prevention of sudden death.
Klein MH; Gold MR
Cardiol Clin; 2008 Aug; 26(3):419-31, vi-vii. PubMed ID: 18538188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
